Dovitinib Plus Docetaxel in Gastric Cancer

NCT01921673 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Dovitinib and docetaxel

Sponsor

Asan Medical Center

Collaborators

[object Object]